GRI Bio, Inc. (GRI): Total Assets
$8.67M
As of 2025-12-31
$11.38M
As of 2026-06-30
+182.8%
3-year compound annual growth
+55.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.67M | +51.0% | 2026-01-30, Balance as of period end |
| 2024-12-31 | $5.74M | +94.1% | 2026-01-30, Balance as of period end |
| 2023-12-31 | $2.96M | +671.8% | 2025-03-14, Balance as of period end |
| 2022-12-31 | $383.0K | -95.4% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $8.34M | +772.8% | 2023-02-24, Balance as of period end |
| 2020-12-31 | $955.0K | n/a | 2022-02-14, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| GRI Bio, Inc. (GRI) | 2025-12-31 | $8.67M | +51.0% |
| CNS Pharmaceuticals, Inc. (CNSP) | 2025-12-31 | $8.62M | -0.9% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $8.75M | -11.7% |
| Nanoviricides, Inc. (NNVC) | 2025-06-30 | $8.82M | -31.2% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $8.97M | +26.9% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| Revium Rx. (RVRC) | 2025-12-31 | $8.30M | -59.1% |
| Lunai Bioworks Inc. (LNAI) | 2025-06-30 | $8.23M | -95.0% |
| ProMIS Neurosciences Inc. (PMN) | 2025-12-31 | $9.18M | -51.4% |
Compare GRI, CNSP, IGC, NNVC side by side · Screen every company in Pharmaceutical Preparations ↗